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Abstract Hyperphosphorylated tau is the major component of
paired helical filaments in neurofibrillary tangles found in
Alzheimer’s disease brains, and tau hyperphosphorylation is
thought to be a critical event in the pathogenesis of this disease.
The objective of this study was to reproduce tau hyperphos-
phorylation in an animal model by inducing hypoglycemia. Food
deprivation of mice for 1 to 3 days progressively enhanced tau
hyperphosphorylation in the hippocampus, to a lesser extent in
the cerebral cortex, but the effect was least in the cerebellum, in
correspondence with the regional selectivity of tauopathy in
Alzheimer’s disease. This hyperphosphorylation was reversible by
refeeding for 1 day. We discuss possible mechanisms of this
phenomenon, and propose the starved mouse as a simple model to
study in vivo tau phosphorylation and dephosphorylation which
are altered in Alzheimer’s disease.
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1. Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder
characterized by the presence in the brain of two histopatho-
logical hallmarks called senile plaques and neuro¢brillary tan-
gles (NFT) [1,2]. NFT are structures present in the neuronal
body and consist of paired helical ¢laments (PHF), mainly
composed of highly phosphorylated tau protein [3]. Tau is a
microtubule-associated protein expressed mostly, but not ex-
clusively, in the nervous system, and its normal physiological
function is to bind and stabilize microtubules. Tau is ‘hyper-
phosphorylated’ in AD brains (PHF-tau) [3], to contain up to
four times as much phosphate [4], and also at sites that are
not phosphorylated in the brains of normal human adults [5].
This hyperphosphorylation has been shown to reduce the
binding a⁄nity of tau for microtubules in vitro [6]. These
observations have given rise to the hypothesis that tau hyper-
phosphorylation would lead to microtubule destabilization,
appearance of NFT, and neurodegeneration in AD [7]. Re-
cently, mutations in the tau gene have been shown to be
responsible for FTDP-17, and there is a growing recognition
that tauopathy may be a common converging point of patho-
genic processes of a number of neurodegenerative diseases
including AD [8].
AD brains have been widely reported to show regional
reductions in glucose transport and utilization [9]. The brain
depends on glucose for most of its energy needs and is thus
highly vulnerable to diminished availability in glucose [10].
These facts suggest that the decrease in glucose turnover in
the brain may play a role in the pathogenetic mechanisms of
AD [11], and in vitro studies found that glucose deprivation
induces AD-like changes in hippocampal neurons by eliciting
NFT-like tau antigenicity [12].
In the present study we tested whether food deprivation of
adult mice and consequent hypoglycemia may induce AD-like
tau hyperphosphorylation in the brain by examining the levels
of tau phosphorylation through immunoblotting with a bat-
tery of anti-tau antibodies speci¢c to phosphorylated or non-
phosphorylated epitopes [13]. Starvation up to 3 days revers-
ibly induced tau hyperphosphorylation in the hippocampus,
to a lesser extent in the cortex, but with only a small e¡ect in
the cerebellum. We discuss the possible causative mechanisms
of this hyperphosphorylation with regard to glucose and in-
sulin, and consider the relevance of starvation-induced tau
hyperphosphorylation as a simple and useful model to inves-
tigate the in vivo regulatory mechanisms of tau phosphoryla-
tion and dephosphorylation that are altered in AD.
2. Materials and methods
Eight-week-old C57BL/6NJcl male mice (Clea Japan, Tokyo, Ja-
pan) weighing 20.5 þ 0.5 g were singly housed in cages with grid £oors
to deny coprophagy. Food was removed for up to 3 days, but mice
were allowed free access to water. Room temperature was 23‡C and
the light cycle was 12 h light and 12 h dark.
Rabbit antisera PS199, PS396, PS413 and PS422 are speci¢c to tau
phosphorylated on Ser-199, Ser-396, Ser-413 and Ser-422 (numbering
of amino acid based on the 441 amino acids human tau [14]), respec-
tively, and Tau-C recognizes the C-terminus of tau [13]. Mouse mono-
clonal antibody AT8 (Innogenetics) recognizes tau phosphorylated on
both Ser-202 and Thr-205 [15] and Tau-1 (Boehringer) has an optimal
immunoreactivity when tau is dephosphorylated on Ser-195, Ser-198,
Ser-199, Ser-202 and Thr-205 [16].
Mice were killed by cervical dislocation, brains immediately re-
moved, and hippocampi, cerebral cortices and cerebella were dissected
from brains in ice-chilled PBS. The tissues were quickly weighed and
homogenized in 9Uvolume of bu¡er O+(62.5 mM Tris-HCl pH 6.8,
10% (w/v) glycerol, 5% (v/v) L-mercaptoethanol, 2.3% (w/v) SDS, 100
WM orthovanadate, 1 WM okadaic acid, 1 mM PMSF (phenylmethyl-
sulfonyl £uoride), 1 mM EGTA and 1 mM EDTA). The samples were
then placed in boiling water for 3 min, centrifuged for 10 min at
20 000Ug at room temperature and the protein contents of the super-
natant were determined with the Bio-Rad protein assay with BSA as
standard. Samples were separated by 10% SDS-PAGE and electro-
transferred to nitrocellulose membrane (Protran, Schleicher and
Schuell). The blots were blocked with 3% skim milk in PBS for
30 min at room temperature, washed with PBS and incubated for
2 h at room temperature with primary antibodies. After a second
wash, the blots were incubated with biotinylated anti-rabbit IgG or
biotinylated anti-mouse IgG (Amersham) secondary antibodies for 1 h
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at room temperature. After a third wash, the blots were incubated
with avidin-biotinylated peroxidase complex (Vectastain ABC Kit,
Vector Laboratories) for 40 min at room temperature. After a ¢nal
wash, immunoreactive bands were visualized with 4-chloro-1-naphthol
and H2O2.
3. Results
3.1. Starvation enhances tau phosphorylation most prominently
in the hippocampus
Food deprivation of young adult mice resulted in progres-
sive and severe weight losses (Fig. 1). After 1 day of starvation
the mice lost 20% of their initial body weight and 29% after
2 days.
E¡ect of starvation on the phosphorylation state of tau was
¢rst examined in the cerebral cortex, hippocampus and cere-
bellum. A large mobility shift of tau was observed upon star-
vation for 2 days in the hippocampal extract, as visualized by
a phosphorylation-independent anti-tau antibody, Tau-C
(Fig. 2, Tau-C, Hp lanes). The normal adult tau band of 56
kDa was diminished, and the 60 kDa band greatly intensi¢ed,
with the appearance of 64 kDa and 70 kDa bands. This was
accompanied by even more pronounced enhancement of im-
munostaining by all phosphorylation-dependent anti-tau anti-
bodies tested each speci¢c to ¢ve distinct epitopes (PS199,
AT8, PS396, PS413 and PS422), indicating a large increase
in phosphorylation of tau. This result was corroborated by
a greatly diminished staining of tau bands by Tau-1, which
has an optimal immunoreactivity when tau is dephosphory-
lated on Ser-195, Ser-198, Ser-199, Ser-202 and Thr-205 [16].
When the three brain regions were compared, the enhance-
ment of tau phosphorylation was largest in the hippocampus,
followed by the cerebral cortex with a similar pattern of
changes (Fig. 2). Much smaller e¡ects were observed in the
cerebellum, where the changes were relatively more prominent
with PS413 and PS396. AD tauopathy is known to manifest
earliest in the hippocampal region [17,18]. The rest of the
study, therefore, focused on the hippocampus.
3.2. Development of starvation-induced tau phosphorylation in
the hippocampus
To control for individual variability in the development of
tau phosphorylation, batches of ¢ve young adult mice were
starved for up to 3 days prior to killing, and the results of the
Western blot analysis of hippocampal extracts are shown in
Fig. 3. For ease of comparison, individual samples are pre-
sented, within each batch, in the order of increasing degree of
hyperphosphorylation.
Each antibody showed gradual and progressive changes in
the tau hyperphosphorylation and mobility shift over the
course of 3 days, con¢rming and extending the results of
Fig. 2. There was recognizable individual variation within
batches of 1 or 2 day starvation (cf. lanes 7 vs. 11, or 11 vs.
16), but this was not so large as to overlap with the variability
within the neighboring batches (cf., lanes 11 vs. 12), demon-
strating reproducibility and reliability of our analysis. Thus
phosphorylation of serines at amino acid 199, 396, 413, 422
and at AT8 epitopes become highly enhanced by starvation,
with concomitant decrease in the Tau-1 epitope.
3.3. Reversibility of starvation-induced tau
hyperphosphorylation
Reversibility of starvation-induced tau hyperphosphoryla-
tion was of great interest, as less than complete reversibility
would lead to an accumulation of phosphorylated tau and
eventual formation of NFT-like deposit. Batches of four
mice were starved for 2 days and then allowed access to
food ad libitum for up to 7 days before killing and analysis
of hippocampal tau protein.
After 2 days of starvation the mice weighed about 70%
of their initial weight (Fig. 1) One day of refeeding allowed
Fig. 1. Body weight changes in mice during starvation and refeed-
ing. Batches of 8 week old B6 male mice were starved for 0, 1,
2 and 3 days ([NOCHAR:lozf, solid lines). After 2 days of starva-
tion, some mice were refed for 1, 2 or 7 days (a, broken lines). For
the starved mice, n = 5; except for day 3 (2, n = 2). For the refed
mice, n = 4; except for day 9 (*, n = 3; one mouse excluded, see
text).
Fig. 2. Phosphorylation of tau protein in the hippocampus (Hp),
cerebellum (Cb) and cerebral cortex (Cx), after normal feeding (F)
or 2 days of starvation (S). Immunoblots were incubated with anti-
tau antibodies directed to speci¢c phosphorylated epitopes (polyclo-
nals PS199, PS396, PS413, PS422 and monoclonal AT8), non-phos-
phorylated epitope (monoclonal Tau-1), or a phosphorylation-inde-
pendent epitope (polyclonal Tau-C). R and M correspond to
controls (hippocampus; starved 2 days; no primary antibody) incu-
bated with anti-rabbit or anti-mouse secondary antibodies, respec-
tively.
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them to recover to 85% and 1 week to 110% of their initial
weight. In this experiment, there was one exceptional mouse,
which attained only 93% of its initial weight after 1 week
of refeeding (see below). This mouse was not included in
Fig. 1.
In all the refed animals except one, the hippocampal tau
had reverted to the original phosphorylation state (Fig. 4).
Thus, the starvation-induced hyperphosphorylation is revers-
ible within 1 day. The only but remarkable exception was the
mouse represented in lane 12 of Fig. 4, which did not regain
its initial body weight after 1 week of refeeding. The hippo-
campal phosphorylation pattern of this mouse was similar to
that of 2 day starved mouse (lane 3), suggesting that some
profound change had taken place in the brain of this mouse.
Factors that caused this condition are under investigation.
4. Discussion
The objective of this study was to generate tau hyperphos-
phorylation in an animal model. We speculated that a starva-
tion-induced decrease in brain glucose level might lead to tau
hyperphosphorylation. Our results with adult mice clearly
show that starvation enhances brain tau phosphorylation at
multiple sites, as revealed by immunoblot analysis using phos-
phorylation-dependent antibodies. After 2 days of starvation,
hyperphosphorylation was most pronounced in the hippocam-
pus, with lesser e¡ect in the cerebral cortex, but was nearly
undetectable in the cerebellum (Fig. 2), in correspondence
with the regional selectivity of tauopathy in AD. This phe-
nomenon was reversible by refeeding. Mechanisms behind this
reversible hyperphosphorylation and relevance to AD studies
of the tau hyperphosphorylation model need to be considered.
4.1. Possible mechanisms
Tau protein has many serines and threonines that can be
phosphorylated. Experiments involving phosphatases as well
as phosphorylation of recombinant tau protein by various
kinases [13,19^21] have shown that phosphorylation at certain
serine and threonine residues cause retardation of electropho-
retic migration, called mobility shift, of the tau molecule,
although the responsible residues have not been ¢rmly identi-
Fig. 3. Phosphorylation of tau protein from hippocampus of 8 week
old B6 male mice after normal feeding (lanes 2 to 6), or starved for
1 (lanes 7 to 11), 2 (lanes 12 to 16), or 3 days (17 and 18). Each
lane represents an extract of individual mouse. Lane 1 represents
the pre-stained molecular weight marker. Immunoblots were devel-
oped using various anti-tau antibodies (see legend to Fig. 2).
Fig. 4. Phosphorylation of tau protein from hippocampus of 8 week
old B6 male mice after normal feeding (F, lane 2), 2 days of starva-
tion (S, lane 3); 2 days of starvation followed by 1 day (lanes 4 to
7), 2 days (lanes 8 to 11) or 1 week (lanes 12 to 15) of refeeding.
Each lane represents an extract of individual mouse. Lane 1 con-
tains the pre-stained molecular weight marker. Immunoblots were
developed using various anti-tau antibodies (see legend to Fig. 2).
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¢ed. Since tau occurs in several alternatively spliced forms
with distinguishable molecular weights [19], there is a formal
possibility that some of the apparent mobility shift may ac-
tually be due to changes in isoform composition.
Several of the kinases known to phosphorylate tau have
been reported to be speci¢c to sites included among the epi-
topes investigated in this report [22]. Ser-199 can be phos-
phorylated by tau protein kinase I (TPKI) [23], also called
glycogen synthase kinase 3L (GSK3L), and by extracellular
signal-regulated kinases 1 and 2 (ERK1/2) [24]. Ser-202 and
Thr-205 (AT8 epitope) have been shown to be phosphorylated
by TPKII (cdk5) [13] and other cyclin-dependent kinases, by
ERK1/2 [24], and by 5 stress-activated protein kinases
(SAPK): Jun N-terminal kinase 1 (JNK1 or SAPK1Q) [20],
p38 (SAPK2a) [25], SAPK2b, SAPK3 and SAPK4 [26]. Ser-
396 is phosphorylated by TPKI/GSK3L [23], TPKII [27],
ERK1/2, and the ¢ve SAPKs. Only TPKI/GSK3L is known
to phosphorylate Ser-413 [23], while Ser 422 is phosphorylated
by ERK1/2 and the ¢ve SAPKs [22]. Thus, the mechanisms
responsible for tau hyperphosphorylation here reported need
to be discussed with respect to possible induction of the men-
tioned kinases by decreased glucose or insulin availability
under starvation.
The e¡ects of hypoglycemia on the mammalian brain have
been extensively studied. Deep insulin-induced hypoglycemia
provokes decreases in brain glucose levels and energy state,
excitatory amino acids (EAA) accumulate in the extracellular
space and activate N-methyl-D-aspartate (NMDA) receptors,
leading to excitotoxic neuronal damages in the cerebral cortex
and hippocampus but not in the cerebellum [10]. In a study of
excitotoxicity using rats given kainate intraperitoneally, JNK-
1 activity in the brain was found to be elevated [28]. Activa-
tion of SAPK and ERK was observed upon glutamate appli-
cation to cultured striatal neurons [29]. Recent immunoblot
analysis of increased tau phosphorylation in neuroblastoma
cells upon ionophore-mediated calcium stimulation implicated
TPKI/GSK3L [30].
These reported ¢ndings together with the fact that all the
phosphorylation sites of tau examined in this study show en-
hanced phosphorylation upon starvation suggest that no sin-
gle protein kinase is solely responsible for the phenomenon,
but rather multiple kinases, or possibly a regulated network of
kinases, are involved.
Decreased availability of glucose is expected to a¡ect insu-
lin levels, but the functions and regulation of brain parenchy-
mal insulin are largely unknown. After 2 days of starvation,
the concentration of blood insulin is reduced by 85% in the rat
[31], and it was observed that the brain insulin parallels
changes in blood insulin concentration [32]. In studies based
on cultured cells, SAPK/JNK, MAPK and p38 were found to
be activated by insulin [33], whereas TPKI/GSK3L was down-
regulated [34]. In fact, insulin and insulin-like growth factor 1
(IGF1) have been shown to reduce tau phosphorylation by
inhibiting TPKI/GSK3L in NT2N neuroblastoma cultures
[35].
Thus, reduced levels of both glucose and insulin in the brain
can activate a number of protein kinases to cause hyperphos-
phorylation of tau. Indeed, we have observed a concerted
enhancement of phosphorylation of at least ¢ve distinct sites
on tau that cannot be explained by any single kinase. To
clarify the mechanisms of tau hyperphosphorylation observed
in our study, it will be important in future to determine the
activation states of the protein kinases discussed above during
starvation and study additional conditions, such as pharma-
cological treatments, that a¡ect tau phosphorylation. Our
data also showed that starvation-induced tau hyperphosphor-
ylation is reversible. Therefore, the role of protein phospha-
tases in the regulation of tau phosphorylation levels [36] need
to be studied.
4.2. Relevance of the starved mouse model for AD research
Recent ¢nding that mutations in the tau gene cause devel-
opment of NFT and loss of neurons leading to a type of
dementia [8] lends further support to the idea that some dys-
function associated with hyperphosphorylation of tau is car-
dinal to the pathogenesis of AD as well [7]. Several attempts
have been made to induce tau phosphorylation in the brain of
animal models by injecting various substances such as alumi-
num salts, colchicine and okadaic acid [37]. In non-invasive
experimental approaches using heat-shocked or cold water
stressed rats, transient increase in tau phosphorylation has
also been reported [38,39]. Our study raises the possibility
of making use of starved mice as an in vivo experimental
model to study a particular aspect of AD pathogenesis : tau
hyperphosphorylation.
Neuroimaging studies of AD patients [9] pointed out re-
duced regional glucose metabolism in the regions of the brain
that are most prone to be a¡ected histopathologically in AD
[17,18]. Reduced energy metabolism may be an aggravating, if
not causative, factor in the development of AD. Thus starva-
tion of experimental animals may be considered as a physio-
logically relevant stimulus.
Phosphorylation sites of tau protein here examined and
found to be hyperphosphorylated in the starved mice are all
prominently hyperphosphorylated in PHF-tau from AD
brains [40]. Thus the pattern of phosphorylation of tau is
likely to be analogous between the starved mice and AD pa-
tients.
In incipient AD, tau pathology is known to manifest ear-
liest in the hippocampal region, then to spread to neocortical
regions [17,18], while neuro¢brillary changes are absent in the
cerebellum. In our model mouse tau hyperphosphorylation
was most prominent in the hippocampus, followed by the
neocortex, with the cerebellum showing the least e¡ect. This
parallel in regional selectivity suggests the existence of a com-
mon or overlapping mechanisms of tau hyperphosphorylation
in the starved mice and AD.
These lines of consideration lead us to propose that the
starvation-induced tau phosphorylation may provide a rele-
vant and convenient system to study the pathogenetic mech-
anisms of AD and related neurodegenerative diseases. It will
be important in future to establish this correspondence
through corroboration by immunohistochemical analyses
and identi¢cation of the conditions that can lead to accumu-
lation and deposition of hyperphosphorylated tau in an NFT-
like form. It is hoped that the starved mice will thus shed light
on the critical mechanisms of neurodegeneration.
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